News

Aktie von Kimco Realty: Kurs mit wenig Bewegung (18,1951 €)

Wenig Kursbewegung derzeit bei der Kimco Realty-Aktie . Der jüngste Kurs betrug 21,24 US-Dollar. Wenig getan hat sich heute bislang beim Kurs von Kimco Realty. Mit einem Preis von 21,24 US-Dollar noti ...

CGTN: A peach blossom village at the heart of Xizang's transformation

CGTN published an article highlighting Galai Village, Xizang's "First Peach Blossom Village," and its transformation through improved transportation, tourism ...

Heeros Plc: The arbitral tribunal has confirmed Accountor Finago Oy's redemption right over minority shares in Heeros Plc

EEST The arbitral tribunal appointed by the Redemption Board of the Finland Chamber of Commerce in connection with the redemption proceedings ...

Pelthos Therapeutics, Inc.: Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

Files Quarterly Report on Form 10-Q detailing financial results for legacy operations for the three and six months ended June 30, 2025Strong physician response following successful launch of ZELSUVMI ...

SUNation Energy, Inc.: SUNation Energy Announces 2025 Second Quarter Results and Reiterates Full Year Financial Guidance

FY 2025 Total Sales Expected to Rise 14% - 23% from FY 2024 with Positive Adjusted EBITDA Q2 2025 Select Highlights Gross Margin Expanded to 37%Total Debt Declined by $11.7 Million, a 61% Improvement ...

NexPoint Real Estate Finance, Inc.: NexPoint Real Estate Finance (NREF) Announces Dual Listing on NYSE Texas

NexPoint Real Estate Finance, Inc. (NYSE: NREF) (the "Company") announced today the dual listing of its common stock on NYSE ...

Anixa Biosciences, Inc.: Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial

Fourth Cohort Receiving 30x Initial Dose with No Dose-Limiting Toxicities Observed to Date SAN JOSE, Calif., Aug. 18, 2025 /PRNewswire/ -- Anixa Biosciences, Inc.

Opus Genetics, Inc.: Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1

Phase 1/2 trial expected to initiate in 2H 2025 in patients with BEST1 inherited retinal disease RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD), a clinical ...

RAMFORT lädt zur Abstimmung voraussichtlich ab 3. September / 1ste AGV via AoV*

RAMFORT fordert die Gläubiger ihrer ausstehenden 6,75% p.a. Schuldverschreibungen 2021/26 (DE000 A3H2T4 7) zur Stimmabgabe zwecks Änderungen der Anleihebedingungen auf. - Verschiebung des Rückzahlungs ...

NexPoint Diversified Real Estate Trust (NXDT) Announces Dual Listing on NYSE Texas

DALLAS, Aug. 18, 2025 /PRNewswire/ -- NexPoint Diversified Real Estate Trust ("NXDT") (NYSE: NXDT) announced today the dual listing of its common shares on NYSE ...

Nvni Group Limited: Nuvini Group Unveils New Leadership Incentive Plan, Underscoring Commitment to Shareholders

Strengthens Leadership Incentives and Alignment Around Long-Term Growth Objectives and Disciplined Capital Allocation ~ NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) ...

Legend Biotech USA Inc.: Legend Biotech Appoints Carlos Santos as Chief Financial Officer

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Carlos Santos as the ...